FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Ibuprofen Oral Suspension Recall

Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl

Preferred Pharmaceuticals, Inc · Anaheim, CA

Risk level
Class II
Reported by FDA
Dec 4, 2019
Recall ID
D-0531-2020
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Ibuprofen Oral Suspension starting Nov 21, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0531-2020 on Dec 4, 2019. Reason: Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing. Status: Terminated.

Why it was recalled

Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Product description

Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01

Lot numbers, UPCs & expiration codes

Lot #: I1718U, Exp. 3/2020; K0818L, Exp. 9/2020; L2718E, Exp. 9/2020; A2219E, Exp. 9/2020; C1519S, Exp. 12/2020; C2819Y, Exp. 12/2020; E2019V, Exp. 11/2020

Where it was sold

CA, FL, IL

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0531-2020
Classification
Class II
Status
Terminated
Recall initiated
Nov 21, 2019
FDA report date
Dec 4, 2019
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc

Original FDA data

Every field from FDA enforcement report D-0531-2020, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
84359
Address
1250 N Lakeview Ave Ste O
Code information
Lot #: I1718U, Exp. 3/2020; K0818L, Exp. 9/2020; L2718E, Exp. 9/2020; A2219E, Exp. 9/2020; C1519S, Exp. 12/2020; C2819Y, Exp. 12/2020; E2019V, Exp. 11/2020
Postal code
92807-1801
Report date
Dec 4, 2019
Product type
Drugs
Recall number
D-0531-2020
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc
Termination date
May 11, 2023
Reason for recall
Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01
Distribution pattern
CA, FL, IL
Recall initiation date
Nov 21, 2019
Initial firm notification
Telephone
Center classification date
Nov 27, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0531-2020, published Dec 4, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls